Erin Fleming

Company: ProJenX

Job title: Chief Operating Officer

Seminars:

AI-Generated Digital Twins in ALS: Improving Confidence in Early-Stage Studies 2:00 pm

PRO-101 – Study Overview: a Phase 1 clinical trial evaluating prosetin—a first-in-class MAP4 kinase (MAP4K) inhibitor AI-Powered Digital Twins in – PRO-101 – Enhancing data robustness and interpretation in ALS studies Using Digital Twins as an External Control – Leveraging AI to support early-stage data analysis for more informed decisionmakingRead more

day: Conference Day One Track B PM